MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

Cassava Sciences Inc

Geschlossen

BrancheGesundheitswesen

3.97 15.74

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

3.42

Max

3.98

Schlüsselkennzahlen

By Trading Economics

Einkommen

-21M

-44M

Gewinnspanne

-2,258.347

Angestellte

30

EBITDA

-21M

-45M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+133.92% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

6. Nov. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

64M

172M

Vorheriger Eröffnungskurs

-11.77

Vorheriger Schlusskurs

3.97

Nachrichtenstimmung

By Acuity

49%

51%

189 / 371 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Weak Bearish Evidence

Cassava Sciences Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

8. Okt. 2025, 20:45 UTC

Ergebnisse

Costco Wholesale Sales Climb in September, Early October

8. Okt. 2025, 20:12 UTC

Wichtige Markttreiber
Akquisitionen, Fusionen, Übernahmen

TaskUs Shares Fall After Holders Reject Take-Private Deal

8. Okt. 2025, 16:39 UTC

Wichtige Markttreiber

Mining Shares Rise as Gold Prices Soar

8. Okt. 2025, 23:45 UTC

Market Talk

Nikkei May Rise on Weaker Yen -- Market Talk

8. Okt. 2025, 23:43 UTC

Market Talk

Gold Falls on Possible Profit-Taking -- Market Talk

8. Okt. 2025, 23:18 UTC

Akquisitionen, Fusionen, Übernahmen

JD Logistics to Finance Acquisition Using Internal Funds

8. Okt. 2025, 23:17 UTC

Akquisitionen, Fusionen, Übernahmen

JD Logistics to Buy On-Demand Delivery Services Business for US$270.0M

8. Okt. 2025, 23:16 UTC

Akquisitionen, Fusionen, Übernahmen

JD Logistics to Buy JD.com's On-Demand Delivery Services Business Dajiang and Dasheng

8. Okt. 2025, 21:54 UTC

Market Talk
Ergebnisse

James Hardie Could Beat Annual Earnings Goal -- Market Talk

8. Okt. 2025, 21:30 UTC

Market Talk

Boab Metals Bull Delivers Second Upgrade in a Month -- Market Talk

8. Okt. 2025, 21:26 UTC

Market Talk
Ergebnisse

Transurban's 1Q Traffic Growth Beats Hopes -- Market Talk

8. Okt. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. Okt. 2025, 19:15 UTC

Market Talk

Geopolitical Risk Supports Gains in Oil Futures -- Market Talk

8. Okt. 2025, 19:01 UTC

Market Talk

U.S. Natural Gas Futures Pull Back Ahead of Storage Data -- Market Talk

8. Okt. 2025, 18:47 UTC

Market Talk

Coca-Cola North America Sales Buoy International Weakness -- Market Talk

8. Okt. 2025, 18:46 UTC

Akquisitionen, Fusionen, Übernahmen

TaskUs: Neither Party Will Be Required to Pay Termination Fee as Result of Planned Mutual Decision to Terminate

8. Okt. 2025, 18:46 UTC

Akquisitionen, Fusionen, Übernahmen

TaskUs Will Remain a Publicly Traded Co >TASK

8. Okt. 2025, 18:46 UTC

Akquisitionen, Fusionen, Übernahmen

TaskUs Does Not Plan to Convene Another Special Meeting of Stockholders >TASK

8. Okt. 2025, 18:45 UTC

Akquisitionen, Fusionen, Übernahmen

TaskUs Didn't Receive Votes Necessary to Approve Transaction Agreement With Affil of Blackstone >TASK

8. Okt. 2025, 18:07 UTC

Market Talk

Mexico's Inflation Seen Edging Up in September -- Market Talk

8. Okt. 2025, 16:20 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Energy & Utilities Roundup: Market Talk

8. Okt. 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. Okt. 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8. Okt. 2025, 15:57 UTC

Market Talk

Oil Rises Despite U.S. Crude Stockpiles Build -- Market Talk

8. Okt. 2025, 15:56 UTC

Market Talk

Teck Resources' Chile Mine Issues Appear Transitory -- Market Talk

8. Okt. 2025, 15:53 UTC

Market Talk

Argentine Sovereign Debt Seen as Attractive -- Market Talk

8. Okt. 2025, 15:44 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical: Broadwood's Proposal to Vote Down Merger Could Allow It to Take Control Without Paying Any Premium

8. Okt. 2025, 15:44 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical Board and Management Disagree With Recommendation Issued by Glass Lewis >STAA

8. Okt. 2025, 15:43 UTC

Akquisitionen, Fusionen, Übernahmen

STAAR Surgical Board Reiterates Unanimous Recommendation Holders Vote for Alcon Merger

8. Okt. 2025, 15:42 UTC

Akquisitionen, Fusionen, Übernahmen

Oracle Is a Buy-the-Dip Opportunity, Analyst Says. How the Stock Could Rise 23%. -- Barrons.com

Peer-Vergleich

Kursveränderung

Cassava Sciences Inc Prognose

Kursziel

By TipRanks

133.92% Vorteil

12-Monats-Prognose

Durchschnitt 8 USD  133.92%

Hoch 8 USD

Tief 8 USD

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Cassava Sciences Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

1 ratings

1

Buy

0

Halten

0

Sell

Technischer Score

By Trading Central

1.56 / 1.7Unterstützung & Widerstand

Kurzfristig

Weak Bearish Evidence

Mittelfristig

Strong Bullish Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

189 / 371 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Cassava Sciences Inc

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.
help-icon Live chat